Scribe Therapeutics Inc. is a clinical-stage biotechnology company. The Company develops CRISPR-based genetic medicines for the treatment of cardiovascular and metabolic diseases. Scribe Therapeutics operates in the United States.
more
Refresh
No presentations found
We’ll display presentations we find for Scribe Therapeutics here